Trinity College Dublin

Skip to main content.

Top Level TCD Links

Spinout Companies

Trino Therapeutics
Founded by Assoc. Prof. Neil Frankish
& Assoc. Prof. Helen Sheridan
http://www.trinotherapeutics.com
Trino’s lead candidate has shown excellent activity in pre-clinical models of Inflammatory Bowel Disease, most commonly expressed as ulcerative colitis or Crohn’s disease (CD). First-in-man clinical trials will commence in Q1, 2014.

 

 

 

 

 

 

 

Solvotrin Therapeutics
Founded by Assoc. Prof. John Gilmer
http://www.solvotrin.com
Solvotrin’s lead product ST0702 has major benefits to offer as an anti metastatic agent in colorectal cancer due to its aspirin anti-platelet effects, with additional super-aspirin de-cloaking effects of its lipophilic metabolite.

 

 

 

 

Back to top


Last updated 15 November 2016 by School of Pharmacy & Pharmaceutical Sciences (Email).